The American Society of Clinical Oncology (ASCO) and CollabRx, an organization that leverages information technology to personalize cancer treatments and accelerate research, have partnered to develop innovative, Web-based decision support tools that enable people to better understand emerging cancer therapies and the specific genetic profiles of tumors that these drugs target.

The partnership will initially focus on melanoma in the context of CollabRx's Targeted Therapy Finder - Melanoma, which is an online "app" that enables people to identify diagnostic tests, treatments, and clinical trials associated with unique molecular profiles of melanoma.

Patients can access this free tool via ASCO’s patient information website, Cancer.Net, at www.cancer.net/targetedtherapyfinder.

Read more about the ASCO-CollabRx partnership.

Last Updated: April 06, 2011